Immune cell dysfunction and inflammation in end-stage renal disease

@article{Betjes2013ImmuneCD,
  title={Immune cell dysfunction and inflammation in end-stage renal disease},
  author={M. G. Betjes},
  journal={Nature Reviews Nephrology},
  year={2013},
  volume={9},
  pages={255-265}
}
  • M. G. Betjes
  • Published 2013
  • Medicine
  • Nature Reviews Nephrology
  • Uraemia causes inflammation and reduces immune system function as evidenced by an increased risk of viral-associated cancers, increased susceptibility to infections and decreased vaccination responses in patients with end-stage renal disease (ESRD). The substantially increased risk of atherosclerosis in these patients is also probably related to uraemia-associated inflammation. Uraemia is associated with a reduction in the number and function of lymphoid cells, whereas numbers of myeloid cells… CONTINUE READING
    210 Citations

    Paper Mentions

    OBSERVATIONAL CLINICAL TRIAL
    The current incidence of chronic kidney disease (CKD) in China is approximately 10.8%, with approximately 119 million patients. Among them, patients with end-stage renal disease (ESRD… Expand
    ConditionsInflammation, Peritoneal Dialysis
    InterventionOther
    Loss of Renal Function Causes Premature Aging of the Immune System
    • 47
    Immune Dysfunction in Uremia 2020
    Uremia-Associated Ageing of the Thymus and Adaptive Immune Responses
    • 1
    • PDF
    The effect of end-stage renal disease on innate and adaptive immunity
    Immunology of the ageing kidney
    • 12
    Chronic kidney disease : a complex network of leukocyte dysfunction and inflammation
    Uraemia-induced immune senescence and clinical outcomes in chronic kidney disease patients.
    • T. Crépin, Mathieu Legendre, +10 authors J. Bamoulid
    • Medicine
    • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
    • 2018
    • 13
    • PDF

    References

    SHOWING 1-10 OF 142 REFERENCES
    Aspects of immune dysfunction in end-stage renal disease.
    • 529
    • PDF
    Oxidative stress in end-stage renal disease: an emerging threat to patient outcome.
    • 661
    • PDF
    Effects of end-stage renal disease and haemodialysis on dendritic cell subsets and basal and LPS-stimulated cytokine production.
    • 52
    • PDF
    T cells and B cells in chronic renal failure.
    • 119